Houston, TX, United States of America

Christopher Bristow

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
4 patents (USPTO):

Title: Christopher Bristow: Innovator in Cancer Treatment

Introduction

Christopher Bristow is a notable inventor based in Houston, Texas, recognized for his contributions to cancer treatment through innovative therapies. With a total of four patents to his name, Bristow has made significant strides in the field of medical research, particularly in the area of glutaminase inhibitor therapy.

Latest Patents

Bristow's latest patents focus on methods for treating tumors or cancers in subjects whose cancer cells express low levels of asparagine synthetase (ASNS). These patents disclose compounds and compositions that are useful in such treatments. Additionally, they outline methods for evaluating whether to administer a compound that inhibits glutathione production or a glutaminase inhibitor to a subject with a tumor or cancer.

Career Highlights

Christopher Bristow is affiliated with the University of Texas System, where he continues to advance his research and innovation in cancer therapies. His work has the potential to significantly impact the treatment options available for patients suffering from various forms of cancer.

Collaborations

Bristow collaborates with esteemed colleagues such as Timothy P. Heffernan and Jeffrey Kovacs, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Christopher Bristow's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patents and ongoing research efforts are paving the way for new treatment methodologies that could benefit countless patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…